Using a special tourniquet for severe abdominal bleeding in trauma patients
Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage: a Prospective Observational Pilot Study
This study is testing a special tourniquet to see if it can help trauma patients with severe abdominal bleeding in emergency situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Trial ID | NCT06622317 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the feasibility of the Abdominal Aortic Junction Tourniquet (AAJT-S) in patients experiencing life-threatening lower body trauma with non-compressible truncal hemorrhage. It aims to assess the device's application in emergency and pre-hospital settings, focusing on its effectiveness in trauma resuscitation. The study will observe patients who are already receiving this intervention as part of routine clinical practice, rather than introducing a new treatment protocol.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with confirmed or suspected life-threatening lower body trauma and signs of inadequate tissue perfusion.
Not a fit: Patients with suspected additional bleeding sources above the umbilicus or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve survival rates in trauma patients suffering from severe abdominal bleeding.
How similar studies have performed: While the AAJT-S has been used in clinical settings, this specific observational approach to evaluate its feasibility is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged, or believed to be aged, 18 years or above, * confirmed or suspected life-threatening lower body trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss) * is thought to benefit from trauma resuscitation with AAJT-S or REBOA zone III Exclusion Criteria: * suspected additional bleeding source proximal to the umbilicus, or * known or suspected pregnancy at presentation, or * known abdominal aortic aneurysm
Where this trial is running
Graz, Styria
- Medical University of Graz — Graz, Styria, Austria (Recruiting)
Study contacts
- Study coordinator: Gabriel Honnef, MD, PhD
- Email: gabriel.honnef@medunigraz.at
- Phone: 004331638581283
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.